Escitalopram treatment of pathological gambling with co-occurring anxiety: An open-label pilot study with double-blind discontinuation

International Clinical Psychopharmacology

Volumn 21, Issue 4, 2006, Pages 203-209

  Grant, Jon E ^a   Potenza, Marc N ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Anxiety; Gambling; Pharmacology; Treatment

Indexed keywords

ESCITALOPRAM;

ACUTE STRESS DISORDER; ADULT; AGED; ANORGASMIA; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HEADACHE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATHOLOGICAL GAMBLING; PERCEIVE STRESS SCALE; PHOBIA; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SHEEHAN DISABILITY SCALE; SIDE EFFECT; SOCIAL PHOBIA; SYMPTOMATOLOGY; TREATMENT RESPONSE; YALE BROWN OBSESSIVE COMPULSIVE SCALE MODIFIED FOR PATHOLOGICAL GAMBLING;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CITALOPRAM; DOUBLE-BLIND METHOD; FEMALE; GAMBLING; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS;

EID: 33646710977     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200607000-00002     Document Type: Article

References (36)

1. Argo TA, Black DW (2004). Cognitive and behavioral treatments. In: Grant JE, Potenza MN, editors. Pathological gambling: a clinical guide to treatment. Washington, DC: APPI.
2. Black DW, Moyer T (1998). Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 49:1434-1439.
3. Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J (2002). A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 14:9-15.
4. Bland RC, Newman SC, Orn H, Stebelsky G (1993). Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 38:108-112.
5. Blaszczynski A, McConaghy N, Frankova A (1989). Crime, antisocial personality, and pathological gambling. J Gambling Behav 5:137-152.
6. Cohen S, Kamarck T, Mermelstein R (1983). A global measure of perceived stress. J Health Soc Behav 24:385-396.
7. Cunningham-Williams RM, Cottler LB, Compton WM III, Spitznagel EL (1998). Taking chances: problem gamblers and mental health disorders - results from the St Louis Epidemiologic Catchment Area study. Am J Public Health 88:1093-1096.
8. First MB, Spitzer RL, Gibbon M, Williams JBW (1995). Structured Clinical Interview for DSM-IV-patient edn (SCID-I/P, version 2.0). New York, New York: Biometrics Research Department, New York State Psychiatric Institute.
9. Frisch MB, Cornell J, Villaneuva M (1993). Clinical validation of the Quality of Life Inventory: a measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess 4:92-101.
10. Grant JE, Kim SW (2001). Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry 62:957-962.
11. Grant JE, Kim SW (2005). Quality of life in kleptomania and pathological gambling. Compr Psychiatry 46:34-37.
12. Grant JE, Kim SW, Potenza MN, Blnaco C, Ibanez A, Stevens L, et al. (2003). Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. Int Clin Psychopharmacol 18:243-249.
13. Grant JE, Steinberg MA, Kim SW, Rounsaville BJ, Potenza MN (2004). Preliminary validity and reliability testing of a structured clinical interview for pathological gambling (SCI-PG). Psychiatry Res 128:79-88.
14. Grant JE, Levine L, Kim D, Potenza MN (2005). Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162:2184-2188.
15. Guy W (1976). ECDEU Assessment manual for psychopharmacology. US Department Health, Education and Welfare publication (ADM) 76-338. Rockville, Maryland: National Institute of Mental Health. pp. 218-222.
16. Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychiatry 32:50-55.
17. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
18. Hodgins DC, Petry NM (2004). Cognitive and behavioral treatments. In: Grant JE, Potenza MN, editors. Pathological gambling: a clinical guide to treatment. Washington, DC: APPI.
19. Hollander E, Buchalter AJ, DeCaria C (2000a). Pathological gambling. Psychiatr Clin North Am 23:629-642.
20. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C (2000b). A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry 47:813-817.
21. Hollander E, Kaplan A, Pallanti S (2004). Pharmacological treatments. In: Grant JE, Potenza MN, editors. Pathological gambling: a clinical guide to treatment. Washington, DC: APPI.
22. Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N (2005). Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162:137-145.
23. Kim SW, Grant JE, Adson DE, Shin YC (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49:914-921.
24. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R (2002). A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 63:501-507.
25. Lesieur HR, Blume SB (1987). The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144:1184-1188.
26. Linden RD, Pope HG Jr, Jonas JM (1986). Pathological gambling and major affective disorder: preliminary findings. J Clin Psychiatry 47:201-203.
27. Maier W, Buller R, Philipp M, Heuser I (1988). The Hamilton Anxiety Scale: reliability, validity, and sensitivity to change in anxiety and depressive disorders. J Affect Disord 14:61-68.
28. National Opinion Research Center (1999). Gambling impact and behavior study. Chicago, Illinois: University of Chicago.
29. Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E (2005). Reliability and validity of the Pathological Gambling Modification of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambling Stud 21:431-443.
30. Pasternak AV, Fleming MF (1999). Prevalence of gambling disorders in a primary care setting. Arch Fam Med 8:515-520.
31. Potenza MN, Steinberg MA, McLaughlin SD, Rounsaville BJ, O'Malley SS (2000). Illegal behaviors in problem gambling: analysis of data from a gambling helpline. J Am Acad Psychiatry Law 28:389-403.
32. Roy A, Ardinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V, et al. (1988). Pathological gambling: a psychobiological study. Arch Gen Psychiatry 45:369-373.
33. Shaffer HJ, Hall MN, Vander Bilt J (1999). Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Pub Health 89:1369-1376.
34. Sheehan DV (1983). The anxiety disease. New York, New York: Scribner's.
35. Waugh J, Goa KL (2003). Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs 17:343-362.
36. Zimmerman M (2005). What role do anxiety disorders play in the treatment of depression? Psychiatr Times 11(Suppl):1-8.